Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/27539
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSriklung K.
dc.contributor.authorApiratikul N.
dc.contributor.authorSamosorn S.
dc.contributor.authorNarkwichean A.
dc.contributor.authorWatanapokasin R.
dc.date.accessioned2022-12-14T03:17:35Z-
dc.date.available2022-12-14T03:17:35Z-
dc.date.issued2022
dc.identifier.issn1252208
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85123381701&doi=10.35755%2fjmedassocthai.2022.S01.00017&partnerID=40&md5=af7e87600bcdeb7daf444654acfd8cb8
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/27539-
dc.description.abstractBackground: The dried stem of Derris scandens Benth. is well known as an Asian medicinal plant and is used for a variety of ailments. It is claimed to used for the relief of muscle aches and pain and revealed the presence of compounds that appear to modify inflammatory processes. Chemical analysis of D. scandens have revealed the presence of numerous isoflavone derivatives. Lupalbigenin, prenylated isoflavone is a key component of D. scandens stem ethanolic extract. Its anti-inflammatory activity in cell culture had never previously been reported which is why this study was performed. Objective: To investigate the inflammatory activity through molecular signaling pathways of lupalbigenin from D. scandens aqueous ethanol extract using LPS-induced cell changed in Raw 264.7 macrophages cells. Materials and Methods: Lupalbigenin was purified from aqueous extract of dried stem of D. scandens. Cell viability of lupalbigenin in Raw 264.7 cell was determined by MTT assay. Griess reagent has been used for nitric oxide determination. The protein expression of iNOS, cyclooxygenase-2 (COX-2), TNF-α, NF-κB and MAPK were performed by Western blotting. In addition, we also used immunofluorescent assay to examine the NF-κB translocation from nucleus to cytoplasm. Results: Lupalbigenin at 1.25 and 2.5 mM effectively inhibited the LPS-induced tumor necrosis factor-alpha (TNF-α), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) as well as nuclear factor kappa B (NF-κB). In addition, lupalbigenin prevented LPS-induced inflammation by decreasing p38 and JNK expression in mitogen-activated protein kinase (MAPK) pathway. Conclusion: Lupalbigenin at low concentrations showed down-regulation of inflammatory gene and protein expressions as well as inhibiting NF-κB translocation. Lupalbigenin could be used as an anti-inflammatory agent. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
dc.languageen
dc.subjectantiinflammatory agent
dc.subjectcyclooxygenase 2
dc.subjectDiodia scandens extract
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectisoflavone derivative
dc.subjectlipopolysaccharide
dc.subjectlupalbigenin
dc.subjectmitogen activated protein kinase
dc.subjectnitric oxide
dc.subjectnitric oxide synthase
dc.subjectsynaptophysin
dc.titleLupalbigenin Inhibiting NF-κB Translocation Associated with Anti-Inflammatory Responses in Lipopolysaccharide Stimulated RAW 264.7 Macrophages
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 105, No. (2022), p.S32-S38
dc.identifier.doi10.35755/jmedassocthai.2022.S01.00017
Appears in Collections:Scopus 2022

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.